BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

In exciting news for the Korean pharma, the industry in Korea has seen its ‘growth potential’ increase by 7% in the 2023 CPHI Annual Survey[1]....

August 11, 2023 | News

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it is collaborating with N...

August 11, 2023 | News

Positive Phase 3 Results for Fasedienol Nasal Spray in Social Anxiety Disorder by AffaMed's Partner Vistagen

First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years Statistically significant rapid-onset reducti...

August 11, 2023 | News

SK bioscience Announces Equity Investment in Novavax to Strengthen Strategic Partnership

SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...

August 09, 2023 | News

Certara Teams Up with Korea Institute of Toxicology for FDA-Ready SEND Dataset

Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...

August 04, 2023 | News

Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market

Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...

July 31, 2023 | News

GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer

''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...

July 27, 2023 | News

South Korea's GC Biopharma's 'GC FLU' Vaccine Approved in Egypt

Striving to further expand its territory to Africa and the Middle East from Southeast Asia and Latin America "Will cr...

July 24, 2023 | News

US FDA Grants Orphan Drug Designation to SN Bioscience's 'SNB-101' for Small Cell Lung Cancer

SNB-101 showed excellent efficacy in animal small cell lung cancer models, and based on this, it has been designated as an orphan drug by the US FDA after ...

July 21, 2023 | News

Samsung Biologics releases 2023 ESG Report

Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social an...

July 19, 2023 | News

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...

July 18, 2023 | News

SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'

SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutti...

July 18, 2023 | News

3D bioprinting technology to be used for removing cancer cells

□ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...

July 11, 2023 | News

Transcenta Receives Approvals for Global Phase III Trial of Osemitamab (TST001)

To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...

July 10, 2023 | News

Stay Connected